Cenegermin: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Cenegermin. Educational only — not medical advice.
Labeled uses
OXERVATE® (cenegermin-bkbj) ophthalmic solution 0.002% is indicated for the treatment of neurotrophic keratitis.
Source: FDA labeling via NIH DailyMed (set 89e4bfec…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.